Journal article
Implementation of Liquid Biopsy in Non-Small-Cell Lung Cancer: An Ontario Perspective
Abstract
Lung cancer is the leading cause of cancer-related deaths in Canada, with non-small-cell lung cancer (NSCLC) accounting for the majority of cases. Timely access to comprehensive molecular profiling is critical for selecting biomarker-matched targeted therapies, which lead to improved outcomes in advanced NSCLC. Tissue biopsy samples are the gold standard for molecular profiling; however, several challenges can prevent timely and complete …
Authors
Breadner D; Hwang DM; Husereau D; Cheema P; Doucette S; Ellis PM; Kassam S; Leighl N; Maziak DE; Selvarajah S
Journal
Current Oncology, Vol. 31, No. 10, pp. 6017–6031
Publisher
MDPI
DOI
10.3390/curroncol31100449
ISSN
1198-0052